Verrica pharmaceuticals appoints noah l. rosenberg, m.d.

West chester, pa., march 26, 2025 (globe newswire) -- verrica pharmaceuticals inc. (“verrica” or the “company”) (nasdaq: vrca), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of noah l. rosenberg, m.d., as chief medical officer.

NOAH Ratings Summary

NOAH Quant Ranking